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ABSTRACT 
     Intestinal normal flora can become reservoirs of antibiotic resistance genes present among the strains 
responsible for nosocomial infections. It is suggested that gram  negative intestinal bacterial flora have 
increased capacities to obtain antibiotic resistance genes and therefore can act as main reservoirs for 
transfer of resistance genes to other pathogenic bacteria. This study aimed to compare fecal carriage of 
clinically important resistance markers for more frequent members of enterobacteriacae between 
nondiarrheal and community associated diarrheal patients (control group) versus their counterparts from 
the patients with nosocomial infections (case group). 261 stool and 190 clinical samples were collected 
from outpatient and hospitalized patients from 6 hospitals in Tehran, Iran. The samples were cultured on 
MacConkey agar plates and colonies were identified by standard biochemical methods. Antibiotic 
sensitivity testing of the isolates against 13 antibiotics was performed according to the CLSI guideline 
using the disk diffusion method.   Among stool and clinical samples, more frequent identified 
enterobacteriaceae bacteria were included E. coli (58.99/ 3.15%), Klebsiella spp. (22.61/7.36%), and 





generation cephalosporins, gentamicin, imipenem, and ciprofloxacin) was 
significantly higher among the case group (50-75% versus 10-14%). Analysis of these results showed 
similar dissemination of resistance phenotypes among the isolates from the control group in ranges of 
1.5-7.6% and 4.4% for E. coli and Klebsiella spp., respectively. Our results suggested that the fecal 
carriage of resistant phenotypes related to the β-lactam antibiotics in E. coli and Klebsiella spp. in 
compare to the clinical isolates is rapidly increasing. This may be caused by dissemination of β-
lactamase producing E. coli in the community from the hospitals. There were no significant correlations 
between the two groups of the samples, as the clinical samples had shown 3 to 7 folds excess resistance 
phenotypes. Surveillance studies of the resistance patterns among the samples from different regions will 
provide awareness about dissemination of these bacteria within the community as reservoirs of main 
resistance markers.  
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INTRODUCTION 
   The most complex ecosystems known in 
microbial ecology is  the human gastrointestinal 
tract, with over 10
11
 bacteria per gram of stool 
[1].  The intestinal normal flora have  several 
significant presence in the digestion of food, 
metabolism of endogenous and exogenous 
compounds, immunopotentiation and 
prevention of colonization by pathogens in the 
gastrointestinal tract and hence is involved in 
society of human health. The intestinal normal 
flora can become reservoirs of antibiotic 
resistance genes [2]. Bacterial resistance to 
antibiotics is a growing problem that results in 
prolonged hospital stays and increased 
morbidity, mortality, and treatment cost. 
Inappropriate antimicrobial use is the main 
factor in development of resistance. In society 
with high antibiotic use, or use of antibiotics 
without prescription, the risk for carriage of 
resistant bacteria often increases. Selective 
pressure of the antibiotics will amplify numbers 
of resistant bacteria in the community. It is 
suggested that gram  negative fecal bacterial 
flora have an increased capacity to obtain 
antibiotic resistance genes and might act as 
reservoirs for transfer of resistance genes to 
other pathogenic bacteria in the communities or 
 




hospitals [3]. Resistance-encoding genetic 
materials are often "clonal" (identical across a 
wide range of bacteria) and can readily move 
between bacteria of the same species and 
different species or genera. Escherichia coli and 
klebsiella pneumonia are members of dominant 
fecal microbiota of the humans. E. coli is a 
major enteric pathogen, particularly in 
developing countries and is the premier 
nosocomial pathogen. Klebsiella spp. are rarely 
associated with intestinal diseases, but 
recognized clinically as responsible agents for 
pneumonia, urinary tract infections, sepsis, and 
infections of surgical wounds.  During the past 
decade, resistance of these bacteria to 
cephalosporin antibiotics has accelerated 
because of the appearance of plasmid-mediated 
horizontally transferrable resistance gene 
markers in these bacteria. 
    Although carriers of resistant organisms in 
the community are suspected, in general 
practice this condition has rarely been reported. 
Previous history of hospitalization and 
antibiotic usage can help persistence and 
dissemination of the resistance bacteria in the 
community and also their transmission into the 
hospitals.  It appeared that resistance against 
some antibiotics, including third-generation 
cephalosporins, gentamicine, vancomycin, 
imipenem, and intravenous fluoroquinolones 
have a higher risk for management of diseases 
[4, 5].  
     This study aimed to compare fecal carriage 
of clinically important resistance markers for 
more frequent members of enterobacteriacae 
between nondiarrheal and community 
associated diarrheal patients (control group) 
versus their counterparts from the patients with 
nosocomial infections (case group). 
 
MATERIALS AND METHODS 
Sample preparation and identification: Total 
of 261 stool samples from outpatients with or 
without diarrhea (control group) between the 
periods of 1 June - 30 October 2010 and 190 
clinical samples from patients with nosocomial 
infections from ICUs of 6 hospitals during the 
period from September 2010 – August 2011, 
were collected during the study.  Records of the 
antibiotic usage, and demographic 
characteristics (age, sex), for the control group 
and hospitalization within the last three months, 
antibiotic prescription, and types of diseases in 
the case group were collected according to the 
standard criteria for nosocomial infections.  
Each homogenized stool sample was cultured 
on MacConkey agar. The microorganisms that 
grew were identified by standard biochemical 
methods. Klebsiella pneumonia strain ATCC 
13883and E. coli strain ATCC 25922 were used 
as control bacteria in all the assays. 
Antibiotic susceptibility testing: Bacterial 
isolates related to species of Klebsiella and E. 
coli were tested for susceptibility to cephalothin 
(CF, 30µg), tetracycline (TE, 30µg), ampicillin 
(AM, 10µg), ceftazidime (CAZ, 30µg), 
gentamicin (GM, 10µg), amoxicillin–clavulanic 
acid (AMC, 30µg), trimethoprim 
sulfamethoxazole (SXT, 300µg), 
chloramphenicol (C , 30µg), ciprofloxacin (CP, 
5µg), cefepime (FEP , 30µg) , carbenicillin (CB 
, 30µg), oxacillin (OX , 10µg), imipenem (IMP 
, 10µg), and EDTA (0.5 M) by Kirby–Bauer 
disk diffusion method and results were recorded 
according to the guidelines recommended by 
the CLSI [8]. Interpretation of results for 
resistance patterns related to the ESBLs and 
carbapenemase producing bacteria was done 
according to the recommendations by Bush et 
al. [12]. 
Statistical analysis: All data were analyzed by 
SPSS software version 11.0 (SPSS Inc, 
Chicago, IL, USA). Comparative statistics were 
calculated using the two-tailed χ2 test and 
Fisher’s exact test, when appropriate. A p-value 
of ≤ 0.05 was considered to be significant. 
Approval by ethics committee: The Ethics 
Committee of Research Center for 
Gastroenterology and Liver diseases, Shahid 
Beheshti University of Medical Sciences, 
approved the study. 
 
RESULTS 
Total of 266 isolates of E. coli, 102 isolates of 
Klebsiella spp. and 40 isolates of other 
members of enterobacteriaceae family were 
identified from 451 samples from 6 hospitals in 
Tehran, Iran. Proportion of the isolation rate for 
the stool (diarrheal and non-diarrheal) and 
clinical samples were 99.58% and 100% in the 
case of E. coli and 36.6% and 9.5% in the case 
of Klebsiella spp., respectively (Table 1). 
Among the studied stool samples (92.3% 
diarrheal and 7.7% non-diarrheal), most of these 
isolates were related to the diarrheal samples. 
Respiratory samples had the highest isolation 
rate of E. coli and Klebsiella spp. among the 
clinical samples. Figure 1 summarizes the 
 




antibacterial susceptibilities of all the isolates 
against the tested antibiotics. Most of the 
isolates from the clinical samples showed multi-
drug resistance phenotypes (MDR), especially 
against more important antibiotics of cefepim, 
ceftazidime, imipenem and gentamicin. 
Comparison of the results for the isolates from 
the control group also showed presence of these 
resistance phenotypes in lower frequencies 
(1.5% to 7.5%). No significant differences were 
found among the isolates from the diarrheal and 
non-diarrheal samples. In general, resistance 
against the tested antibiotics was greater among 
the Klebsiella spp. isolates in the clinical 
samples, but was relatively higher among the E. 
coli isolates in the control samples against 
cefepim and ceftazidime. Seventy five percent 
of the Klebsiella spp. clinical isolates showed 
resistance to ciprofloxacin in compare to 10 % 
for the isolates from control group. Analysis of 
the resistance patterns among the E. coli isolates 
did not support existence of phenotypes related 
to extended spectrum β-lactamase (ESBLs). 
Given the resistance profiles for the clinical 
isolates, in compare to these frequencies among 
the isolates from control group (7.6% and 4.4% 
for E. coli and Klebsiella spp., respectively), it 
was cleared that 50% and 31% of these isolates 
had resistance patterns related to carbapenemase 
producing bacteria. Based on these data, it 
appeared that the isolates in both of the groups 
have highest resistance rates to ampinicillin and 
oxacillin. History of antibiotic usage among 
patients from the control group did not show 
significant correlation with the resistance rates 
(P value ≤ 0.05). 
 
 
Table 1. Frequency of E. coli and Klebsiella spp. isolates among the case and control groups samples. (P value ≤ 0.05) 
 Inpatients Outpatients 
       Diarrheal                       Non-diarrheal 
P value 
E. coli 3.15% 99.58% 100% 0.000 
Klebsiella spp. 6.36% 36.6% 9.5% 0.001 
Other 
enterobacteriaceae 





Table 2. Antimicrobial resistance phenotypes of MDR Klebsialla spp. isolates from case and control group samples. 
Antimicrobial resistance phenotype 
% MDR isolates in 
inpatients 
% MDR isolates 
in 
outpatients 
Cefepim, Gentamicin, Imipenem,  Ceftazidime  31% 4.4% 
Cefepim, Gentamicin, Ceftazidime 23% 4.4% 
Cefepim, Ceftazidime 15.3% 4.4% 
 
Table 3. Antimicrobial resistance phenotypes of MDR E. coli isolates from case and control group samples. 
Antimicrobial resistance phenotype 
% MDR isolates in 
inpatients 
% MDR isolates in 
outpatients 
Co-amoxiclav, Ceftazidime, Cefepime, Imipenem 50% 7.6% 
Co-amoxiclav, Ceftazidime, Imipenem 0% 1.5% 
Co-amoxiclav, Ceftazidime, cefepim 0% 4.2% 









Figure1. Percentage of drug resistance in Klebsiella spp. isolates. 
 
 
Figure2. Percentage of drug resistance in E. coli isolates. 
 
DISCUSSION 
     Resistant strains of enteric bacteria have 
been distributed in some regions of the word. 
Some of these bacteria are responsible for 
severe infections in the community and 
hospitals. Determination of resistance patterns 
among the isolates from each geographic region 
can predict risk of infections with these bacteria 
and needs for new antibiotic types against them.  
Transition of resistance bacteria from the 
hospitals to the community and vise versa, and 
also from food products are established in many 
of studies [6]. Existence of resistance gene 
markers among the non-pathogenic bacteria in 
the environment and their transition to the 
pathogenic bacteria in the community have been 
considered as one of the most important 
strategies for emerging new resistance 
phenotypes in these bacteria. So, healthy 
member of a community can act as main 
reservoirs for these resistance genes. 
     E. coli and Klebsiella spp. are members of 
the enterobacteriacea family that exist in the 
human intestine and are involve in nosocomial 
infections [7]. Comparison of clinically 
important resistance phenotypes among isolates 
of these bacteria from the non-hospitalized 
patients and patients with nosocomial infections 
help us to assess distribution of resistant strains 
within the community [8]. In this study, by 
analyzing more important resistant phenotypes, 
we  found fecal carriage of resistant strains of E. 
 




coli and Klebsiella spp. in a range of 1.5 -7.6 
and 4.4, respectively that was 3 to 7 fold lower 
than the clinical isolates.  In contrast to results 
from some other studies, none of the isolates 
from both of the groups showed resistance 
phenotypes related to ESBLs, but all of the 
imipenem resistant isolates had shown a 
phenotype for carbapenemase producing 
bacteria [13]. The fluoroquinolone resistance 
rate was high in isolates recovered from 
inpatients (75%) that were similar to previous 
report by Abdulla Kader et al., while was lower 
for the isolates in those recovered from 
outpatients (10%) [14]. 
 
CONCULOSION 
     These finding suggests low frequency of 
important resistance markers within the isolates 
from the community.  In the case of the tested 
bacteria in the control group, no significant 
correlation was found between previous usages 
of antibiotics and appearances of the resistant 
phenotypes.  Consumption of food products 
containing resistant bacteria from animal 
sources, arbitrary usage of antibiotics without 
prescription and transition of resistant bacteria 
from medical centers to the community can 
increase risk of this carriage within the 
community. Surveillance studies of the 
resistance patterns among bacterial isolates 
from different regions will provide awareness 
about dissemination of these bacteria within the 
community as reservoirs of main resistance 
markers. More detailed studies will clear these 
associations in future. 
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